Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma
Clinical trial NCT03000179 · TERMINATED
Trial details
- NCT number
- NCT03000179
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-03
- Primary completion
- 2021-08-03
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.